Emergent BioSolutions is down -34.5%, or -$3.40 to $6.46.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on EBS:
- Emergent BioSolutions: Upcoming Quarterly Earnings Discussion
- Emergent BioSolutions introduces NARCANDirect center in Nevada
- Emergent Biosolutions Divests RSDL Rights in $75M Deal
- Emergent BioSolutions Completes Sale of RSDL® (Reactive Skin Decontamination Lotion) Kit to SERB Pharmaceuticals for $75 Million
- Emergent BioSolutions completes sale of RSDL Kit to SERB for $75M